Drug Regulatory Systems Must Foster Innovation
Анотація
We support M.A. Hamburg’s plea for increased funding of regulatory science \n(“Advancing regulatory science,” Editorial, \n25 February, p. 987). We also share her ambition \nto modernize the regulatory system and \nbring 21st-century science and technology to \ndrug development and drug evaluations
Класифікація
Ідентифікатори
Рецензії (0)
Написати рецензіюРецензій ще немає. Будьте першим!
Схожі роботи
Impact of health technology assessment implementation with a special focus on middle-income countries
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
A roadmap towards implementing health technology assessment in Oman
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
Scientific generalization of approaches to the development of the Health Technology Assessment system in international practice
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
Methodological guidelines for Health Technology Assessment in Oman
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
The relevance of training specialists in the Health Technology Assessment in the world and Ukraine
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy